Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol + caffeine versus sumatriptan and placebo for acute migraine
2010-019083-36Phase 4Completed
- Sponsor
- U.O. Tossicologia
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Paracetamol + caffeine, Sumatriptan and Placebo (3 arms). Primary endpoints: Primary efficacy endpoint and Primary safety endpoint. Started Jun 2010; status: completed.
02
Drugs
paracetamol + caffeinesumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2010-019083-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019083-36.